Albany, NY -- (SBWIRE) -- 12/02/2014 -- "Polymerase Chain Reaction (PCR) is a rapid method to amplify DNA in molecular biology field, enabling researchers to produce millions of copies of specific DNA. Though the sample quality is not so good all the time, factors such as short duration, technological advancements and the ease of procedure are boosting its adoption. The global PCR market is expected to grow at a CAGR of more than 9% from 2014 to 2020 to reach a market size of $14 billion by the end of 2020. The PCR market is mainly segmented by products, techniques, applications, and end users. The market assessment of the above mentioned segments is made across the geographies such as North America, Europe, Asia-Pacific, LATAM and MENA.

View Full Report at http://www.marketresearchreports.biz/analysis/234404

Factors such as rising investments in drug discovery technologies and diagnostics, increasing demand for innovative technologies for rapid and accurate diagnosis of life threatening diseases, advanced digital PCR, Patent expiry, increasing applications in the fields of life sciences research, clinical diagnostics and molecular testing are driving the PCR market growth. However, high cost of some of the commercial PCR's, stringent government regulations, emergence of alternate technologies such as Next Generation Sequencing, lack of awareness and shortage of skilled labour are expected to hinder the PCR market growth.

Download Detail Report With Complete TOC at http://www.marketresearchreports.biz/sample/sample/234404

The global PCR market based on products is segmented into instruments, reagents and consumables, software and services. Further segmentation of each of these segments is derived across the geographies. Reagents and consumables commanded the largest market growing at a strong CAGR during the forecast period, whereas the services segment is expected to register a high growth rate. PCR market by techniques is categorized into Real Time PCR / qPCR, standard PCR, reverse transcriptase PCR, digital PCR, assembly PCR, multiplex PCR, hot start PCR and others. Real time quantitative PCR accounted for the largest share in 2013 growing strong, whereas digital PCR market is expected to register the highest CAGR of around 13% during the forecast period

Explore All Latest Published Reports By Xplicit Research at http://www.marketresearchreports.biz/publisher/119

Depending on the applications the PCR market is segmented into clinical diagnostics, industry applications and others. Industry application holds the largest market share and is growing strong, however clinical diagnostics segment is expected to register the highest CAGR of around 11% during the forecast period.

Based on the geography the global PCR market is segmented into North America, Europe, Asia-Pacific, LATAM, and MINA. North America commanded the largest share and is growing at a steady pace. Factors such as enhanced healthcare infrastructures and favorable government funding are responsible for the largest share in this region. However, Asia-pacific region is expected to register the highest CAGR of more than 13% from 2014 to 2020. The growth is mainly attributed to rising healthcare awareness, boosting economic growth and increasing disposable incomes.

The major players in the PCR market are Abbott Laboratories, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Qiagen N.V. (Netherlands), Promega Corporation (U.S.), Sigma Aldrich (U.S.), Roche Diagnostics (Switzerland), Siemens Healthcare (Germany), and Thermo Fisher Scientific, Inc. (U.S.) etc.

The global PCR market report evaluated detailed information about the market trends of diverse segmentation. Further market dynamics, along with challenges, and opportunities are described.

This report provides an in-depth market assessment across the below listed segments:

1. Global Polymerase Chain Reaction Market, by Products:

Instruments
Reagents & Consumables
Software
Services

2. Global Polymerase Chain Reaction Market, by Techniques:

Real Time PCR / qPCR
Standard PCR
Digital PCR
Reverse transcriptase PCR
Multiplex PCR
Hot Start PCR
Assembly PCR
Others

3. Global Polymerase Chain Reaction Market, by Applications:

Clinical diagnostics
Industrial applications
Others

4. Global Polymerase Chain Reaction Market, by End users:

Hospitals and laboratories
Pharma & Biotech firms and CRO's
Academia
Others

5. Global Polymerase Chain Reaction Market, by Geography:

North America
Europe
Asia-Pacific
Rest of World (LATAM, MINA and others)

Related Reports

China Pharmaceutical Excipients Industry Report, 2014-2017

View Full Report at http://www.marketresearchreports.biz/analysis/232334

Pharmaceutical excipients refer to adjuvants and additives used for production of pharmaceuticals and compounding of prescriptions. In addition to active ingredients, pharmaceutical excipients are also contained in pharmaceutical preparations after reasonable safety assessment.

Download Detail Report With Complete TOC at http://www.marketresearchreports.biz/sample/sample/232334

China has launched more than 500 types of pharmaceutical excipients, far less than 1,500 types of the United States and 3,000 types of Europe. By market size, gelatin capsules, sucrose, starch, film-coated powder, 1,2-propylene glycol, polyvinylpyrrolidone (PVP), hydroxypropyl methyl cellulose (HPMC), microcrystalline cellulose, hydroxypropyl cellulose (HPC) and lactose rank as the top 10 pharmaceutical excipients in China.

China Recombinant Protein Drug Industry Report, 2014-2017

View Full Report at http://www.marketresearchreports.biz/analysis/232274

The Chinese recombinant protein drug market has been expanding rapidly owing to the improvement of demand rigidity, consumption ability and the like. During 2005-2013, sales of recombinant protein drugs available in Chinese sample hospitals grew at a CAGR of 19.1%, and it is projected that China will see its actual demand for recombinant protein drugs exceed RMB40 billion in 2014.

Download Detail Report With Complete TOC at http://www.marketresearchreports.biz/sample/sample/232274

The start of recombinant protein drugs in China is not late and common drugs are diversified in variety, for example, recombinant human erythropoietin (rhEPO), recombinant human granulocyte colony-stimulating factor (rhG-CSF) and recombinant human interferon (rhIFN) have gained market approval in the 1990s. Moreover, in 2013, domestic rhG-CSF, rhEPO andrecombinant human growth hormone (rhGH) with price advantage took a respective share of 82.1%, 88.5% and 90.2% in Chinese sample hospitals, and recombinant human interleukin-2/11(rhIL-2/11) was fully localized.

About MarketResearchReports.biz
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Browse Blog at http://2014marketresearch.blogspot.com/